At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

beclomethasonedrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000576

NCT00000576Phase 3Completed

Compare CT.gov

Inhaled Beclomethasone to Prevent Chronic Lung Disease

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Feb 18, 2016

In Brief

A Phase 3 clinical trial evaluating beclomethasone for Bronchopulmonary Dysplasia and 2 related conditions. Completed.

Detailed Summary

To test if inhaled glucocorticoids, early in the course of respiratory failure in premature infants, permit normal lung growth and differentiation, thus preventing development of bronchopulmonary dysplasia.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsBronchopulmonary Dysplasia, Hyaline Membrane Disease, Lung Diseases

Countries--

Collaborators--

Timeline

Phase 3CompletedFinished

19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJun 1993

Study CompletionApr 1999

First PostedOct 1999

TodayJul 2026

First PostedOct 28, 1999

Enrollment StartJun 1, 1993

Study CompletionApr 1, 1999

TodayJul 2, 2026

Posted 26.7 years ago

Interventions

beclomethasonedrug